1. Home
  2. WNC vs RCKT Comparison

WNC vs RCKT Comparison

Compare WNC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WNC

Wabash National Corporation

HOLD

Current Price

$8.18

Market Cap

392.2M

Sector

Industrials

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$4.87

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNC
RCKT
Founded
1985
1999
Country
United States
United States
Employees
N/A
202
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.2M
534.2M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
WNC
RCKT
Price
$8.18
$4.87
Analyst Decision
Hold
Buy
Analyst Count
1
14
Target Price
$11.00
$29.65
AVG Volume (30 Days)
494.5K
2.9M
Earning Date
05-05-2026
01-01-0001
Dividend Yield
3.92%
N/A
EPS Growth
179.22
N/A
EPS
5.07
N/A
Revenue
$2,027,489,000.00
N/A
Revenue This Year
$0.53
N/A
Revenue Next Year
$25.53
$97.68
P/E Ratio
$1.61
N/A
Revenue Growth
8.81
N/A
52 Week Low
$6.78
$2.19
52 Week High
$12.94
$8.80

Technical Indicators

Market Signals
Indicator
WNC
RCKT
Relative Strength Index (RSI) 26.60 58.97
Support Level N/A $2.99
Resistance Level $11.74 $5.34
Average True Range (ATR) 0.44 0.38
MACD -0.23 -0.00
Stochastic Oscillator 6.27 51.16

Price Performance

Historical Comparison
WNC
RCKT

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: